Evidence map›Paper›PMID 39590878›Full record

ReviewMetabolites2024

Influence of Uric Acid on Vascular and Cognitive Functions: Evidence for an Ambivalent Relationship.

Francesco Baratta, Federica Moscucci, Evaristo Ettorre, Raffaella Bocale, Arrigo F G Cicero, Pietro Cirillo, Federica Fogacci, Ilaria Lospinuso, Carmine Savoia, Alessandro Mengozzi and 3 more

Abstract readReview
In one paragraph

Review in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesco BarattaGeriatric Unit, Department of Internal Medicine and Medical Specialties, AOU Policlinico Umberto I, 00161 Rome, Italy.ORCID 0000-0003-1708-272X
Federica MoscucciGeriatric Unit, Department of Internal Medicine and Medical Specialties, AOU Policlinico Umberto I, 00161 Rome, Italy.ORCID 0000-0002-9385-9097
Evaristo EttorreGeriatric Unit, Department of Internal Medicine and Medical Specialties, AOU Policlinico Umberto I, 00161 Rome, Italy.
Raffaella BocaleUnit of Endocrinology, Agostino Gemelli University Hospital Foundation, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Catholic University of the Sacred Heart, 00168 Rome, Italy.
Arrigo F G CiceroCardiovascular Medicine Unit, IRCCS AOU BO, 40138 Bologna, Italy.ORCID 0000-0002-4367-3884
Pietro CirilloNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, "Aldo Moro" University of Bari, 70122 Bari, Italy.ORCID 0000-0003-4164-6978
Federica FogacciHypertension and Cardiovascular Risk Factor Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0001-7853-0042
Ilaria LospinusoGeriatric Unit, Department of Internal Medicine and Medical Specialties, AOU Policlinico Umberto I, 00161 Rome, Italy.
Carmine SavoiaClinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-2296-1959
Alessandro MengozziDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-2834-9725
Agostino VirdisDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-6994-0223
Claudio BorghiCardiovascular Medicine Unit, IRCCS AOU BO, 40138 Bologna, Italy.ORCID 0000-0001-8039-8781
Giovambattista DesideriGeriatric Unit, Department of Internal Medicine and Medical Specialties, AOU Policlinico Umberto I, 00161 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing recognition of the public health impact of cognitive impairment and dementia has sparked a global initiative to identify risk factors and develop strategies to prevent or slow the progression of these cognitive disorders. Uric acid, the end product of the metabolism of purine nucleotides, has been reported as a key factor of many conditions potentially involved in cognitive dysfunction/dementia. In addition, some studies support the hypothesis that elevated uric acid levels could reduce the risk of Alzheimer's disease, slow down the decline of cognition, and delay the progression of Alzheimer's disease, while other evidence achieves opposite positions. These discrepancies might reflect a biological ambivalence for uric acid depending on a very complex interplay of factors that include its concentrations achieved in biological fluids, the nature, and concentration of free radicals, the presence and concentration of other antioxidant molecules, potentially responsible for bi-directional effects of uric acid on brain health/functioning. In this narrative review, we attempt to elucidate the influential role of uric acid metabolism in cognitive functioning by discussing pathophysiological mechanisms putatively involved, being well aware that none of them can be considered one-sided due to the complexity of the human organism.

Indexed as

cardiovascular diseasecerebrovascular diseasecognitive functionuric acid

Identifiers

PMID39590878
PMCPMC11596799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.